Overexpression of ICSBP inhibits bcr-abl induced myeloproliferative disorder

被引：0
作者：
Hao, SX [1 ]
Ren, R [1 ]
机构：
[1] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
375
引用
收藏
页码：92A / 92A
页数：1
相关论文
共 50 条
[41]   Evaluation of hMICL As a Marker Associated with Disease Progression in BCR-ABL Negative Myeloproliferative Neoplasms [J].
Nederby, Line ;
Larsen, Laura Laine ;
Hokland, Peter ;
Roug, Anne Stidsholt .
BLOOD, 2012, 120 (21)
[42]   Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL -Negative Myeloproliferative Neoplasms [J].
Wille, Kai ;
Deventer, Eva ;
Sadjadian, Parvis ;
Becker, Tatjana ;
Kolatzki, Vera ;
Huenerbein, Karlo ;
Meixner, Raphael ;
Jimenez-Munoz, Marina ;
Fuchs, Christiane ;
Griesshammer, Martin .
HAMOSTASEOLOGIE, 2024, 44 (05) :386-392
[43]   High rate of secondary primary malignancies in patients with BCR-ABL negative myeloproliferative neoplasms [J].
Wille, K. ;
Sadjadian, P. ;
Becker, T. ;
Horstmann, A. ;
Kolatzki, V ;
Griesshammer, M. .
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 :28-28
[44]   AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms [J].
Beitzen-Heineke, Antonia ;
Berenbrok, Nikolaus ;
Waizenegger, Jonas ;
Paesler, Sarina ;
Gensch, Victoria ;
Udonta, Florian ;
Delgado, Maria Elena Vargas ;
Engelmann, Janik ;
Hoffmann, Friederike ;
Schafhausen, Philippe ;
von Amsberg, Gunhild ;
Riecken, Kristoffer ;
Beumer, Niklas ;
Imbusch, Charles D. ;
Lorens, James ;
Fischer, Thomas ;
Pantel, Klaus ;
Bokemeyer, Carsten ;
Ben-Batalla, Isabel ;
Loges, Sonja .
HEMASPHERE, 2021, 5 (09) :E630
[45]   The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy [J].
Strickland, Marie ;
Quek, Lynn ;
Psaila, Bethan .
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (05) :1149-1158
[46]   Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasms [J].
Davidson, Marta ;
Wong, Florence ;
Atri, Mostafa ;
Sibai, Hassan ;
Maze, Dawn ;
Cheung, Verna ;
Callum, Jeannie ;
Atenafu, Eshetu G. ;
Gupta, Vikas .
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) :E88-E90
[47]   Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases [J].
La Spina, Enrico ;
Giallongo, Sebastiano ;
Giallongo, Cesarina ;
Vicario, Nunzio ;
Duminuco, Andrea ;
Parenti, Rosalba ;
Giuffrida, Rosario ;
Longhitano, Lucia ;
Li Volti, Giovanni ;
Cambria, Daniela ;
Di Raimondo, Francesco ;
Musumeci, Giuseppe ;
Romano, Alessandra ;
Palumbo, Giuseppe Alberto ;
Tibullo, Daniele .
FRONTIERS IN ONCOLOGY, 2023, 13
[48]   Raft Is Required for Induction of a Bcr-Abl Positive CML Like Myeloproliferative Disease in Mice [J].
Albers, Corinna ;
Illert, Anna Lena ;
Miething, Cornelius ;
Peschel, Christian ;
Duyster, Justus .
BLOOD, 2008, 112 (11) :1100-1100
[49]   Bcr-abl transcript identifiable at low levels in blood in all myeloproliferative disorders. [J].
Singer, IO ;
Sproul, A ;
Tait, RC ;
Soutar, R ;
Gibson, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 :94-94
[50]   Testing in-vitro for imatinib sensitivity in BCR-ABL negative myeloproliferative disorders. [J].
Chase, A ;
Higley, K ;
Baxter, J ;
Grand, F ;
Grand, E ;
Cross, NCP .
BLOOD, 2003, 102 (11) :658A-658A
12345